Home › Funds › Vanguard Group › REGN

Vanguard Group position in REGN

REGENERON PHARMACEUTICALS INC. · Health Care

Latest position (Q4 2025)9.08M sh
Reported value held$7.00B
Portfolio Weight0.10%
First reportedQ1 2021
Last changeHold

Quarter by quarter

QuarterSharesValueChange
Q1 2021 8.00M $3.79B New
Q2 2021 7.97M $4.45B Hold
Q3 2021 8.07M $4.88B Add
Q4 2021 8.16M $5.15B Add
Q1 2022 8.36M $5.84B Add
Q2 2022 8.57M $5.07B Add
Q3 2022 8.65M $5.96B Add
Q4 2022 8.72M $6.29B Add
Q1 2023 8.85M $7.27B Add
Q2 2023 8.86M $6.36B Hold
Q3 2023 8.80M $7.24B Reduce
Q4 2023 8.84M $7.76B Hold
Q1 2024 8.93M $8.60B Add
Q2 2024 8.99M $9.45B Add
Q3 2024 9.32M $9.80B Add
Q4 2024 9.29M $6.61B Hold
Q1 2025 9.41M $5.97B Add
Q2 2025 9.42M $4.95B Hold
Q3 2025 9.05M $5.09B Reduce
Q4 2025 9.08M $7.00B Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding REGN

All REGN fund holders →